CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -57% | -91.3% | 1,153% | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | -539% | -131.8% | 79% | -213.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,233.8% | -1,647.5% | -58.8% | -2,217.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,523.4% | -1,869.8% | -70.7% | -2,364.6% |
| EPS Diluted | -0.27 | -0.28 | -0.13 | -0.34 |
| % Growth | 3.6% | -115.4% | 61.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |